In This Issue:

*Senate Approves Dr. Margaret Hamburg to Head the FDA

*FDA Issues Draft Marketing Guidance for Presenting Drug and Device Risk Information

*President Obama Reverses Former Administration’s Policy on Preemption

*CMS Issues Draft Revised Marketing Guidelines Implementation Plan for HIT under the American Recovery and Reinvestment Act

*OIG’s Recent Advice Focuses on Arrangements Involving Financially Needy Patients

*House and Senate Republicans Unveil Comprehensive Healthcare Reform Proposals

Please see full newsletter for more information.